Get the Stockscreener App
1.225
0.41%
-0.005
After Hours:
1.24
0.015
+1.22%
Oragenics Inc stock is traded at $1.225, with a volume of 43,981.
It is down -0.41% in the last 24 hours and down -6.49% over the past month.
Oragenics, Inc. focuses on developing antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients. Its product candidates also comprise LPT3-04, a naturally occurring dietary substance for weight loss; and SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay. Oragenics, Inc. has collaboration agreements with Intrexon Corporation and its subsidiary, Intrexon Actobiotics NV to develop AG013 as a potential treatment of oral mucositis for cancer patients. It also has license agreements with LPThera LLC to develop LPT3-04, a weight-loss product candidate; and Texas A&M University System for access to new homologs of the lantibiotic Mutacin 1140 (MU1140) and other lantibiotics, as well as holds licenses from the University of Florida Research Foundation, Inc. for MU1140 product candidates. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.
See More
Previous Close:
$1.23
Open:
$1.2
24h Volume:
43,981
Relative Volume:
0.30
Market Cap:
$5.06M
Revenue:
-
Net Income/Loss:
$-20.26M
P/E Ratio:
-0.1434
EPS:
-8.54
Net Cash Flow:
$-8.25M
1W Performance:
-7.20%
1M Performance:
-6.49%
6M Performance:
-78.02%
1Y Performance:
-86.72%
1-Day Range:
$1.19
$1.23
1-Week Range:
$1.19
$1.34
52-Week Range:
$1.01
$18.90
Oragenics Inc Stock (OGEN) Company Profile
Name
Oragenics Inc
Sector
Industry
Phone
813-286-7900
Address
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Compare OGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGEN
Oragenics Inc
|
1.225 | 5.08M | 0 | -20.26M | -8.25M | -8.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Oragenics Inc Stock (OGEN) Latest News
Can you recover from losses in Oragenics Inc.2025 Performance Recap & Weekly High Momentum Picks - newser.com
Why Oragenics Inc. stock is recommended by analysts2025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com
Is Oragenics Inc. stock near bottom after declineJuly 2025 Weekly Recap & Trade Opportunity Analysis - newser.com
Will Oragenics Inc. stock outperform value stocksWeekly Risk Summary & AI Powered Market Trend Analysis - newser.com
Is Oragenics Inc. trending in predictive chart modelsJuly 2025 Highlights & Real-Time Buy Signal Notifications - newser.com
Why Oragenics Inc. stock appears on watchlists2025 Macro Impact & Weekly Momentum Stock Picks - newser.com
Why Oragenics Inc. stock is popular among millennialsMarket Trend Report & Consistent Income Trade Ideas - newser.com
What MACD trends signal for Oragenics Inc. stockDividend Hike & Verified Trade Idea Suggestions - newser.com
What analysts say about Oragenics Inc stockMoving Average Strategies & Free Extraordinary Earning Power - earlytimes.in
How Oragenics Inc. stock performs in weak economyJuly 2025 Drop Watch & Growth Focused Stock Reports - newser.com
Why Oragenics Inc. stock is seen as undervalued2025 Key Highlights & Smart Money Movement Alerts - newser.com
Combining machine learning predictions for Oragenics Inc.July 2025 Selloffs & Verified Momentum Stock Ideas - newser.com
Heatmap analysis for Oragenics Inc. and competitorsWeekly Trend Recap & Community Trade Idea Sharing Platform - newser.com
Analyzing Oragenics Inc. with multi timeframe chartsJuly 2025 Snapshot & Target Return Focused Picks - newser.com
Published on: 2025-10-31 05:02:48 - newser.com
Oragenics Inc. stock outlook for YEAR2025 Risk Factors & Growth Focused Investment Plans - newser.com
Is Oragenics Inc. stock cheap at current valuationQuarterly Earnings Report & Safe Capital Growth Tips - newser.com
What the charts say about Oragenics Inc. todayTrade Entry Report & Low Drawdown Momentum Trade Ideas - newser.com
Does Oragenics Inc. show high probability of reboundInsider Buying & Comprehensive Market Scan Insights - newser.com
What risks investors should watch in Oragenics Inc. stockPortfolio Gains Summary & Free AI Powered Buy and Sell Recommendations - fcp.pa.gov.br
Oragenics Inc Stock (OGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):